The performance of plasma p‐tau217 in Black middle‐aged and older adults
Alzheimer's & Dementia · 2025
DOI: 10.1002/alz.70288 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2025. Verfasst von Gilda E Ennis und 11 weiteren Autor:innen. Beteiligte Einrichtung: Wisconsin Alzheimer's Disease Research Center, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Black or African American, Cardiovascular Diseases, tau Proteins. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIA NIH HHS, National Institute on Aging - National Institutes of Health, Swedish Research Council.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
INTRODUCTION Medical conditions prevalent in Black adults within the United States have been associated with plasma tau phosphorylated at threonine 217 (p‐tau217); however, insufficient p‐tau217 research has been conducted with Black adults. METHODS Participants included n = 233 predominantly cognitively unimpaired adults enrolled in the African Americans Fighting Alzheimer's in Midlife study. Subsamples had creatinine ( n = 137) and positron emission tomography (PET; amyloid‐PET = 65 [amyloid‐PET‐positive = 16/65]; tau‐PET = 70). We tested whether p‐tau217 (ALZPath, Inc.) varied by medical condition and amyloid‐ and tau‐PET‐positivity status and assessed the diagnostic accuracy of p‐tau217. RESULTS Estimated glomerular filtration rate (eGFR)
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Wisconsin Alzheimer's Disease Research Center, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
- Division of Geriatrics and Gerontology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
- Department of Biostatistics and Medical Informatics, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
- Wisconsin Alzheimer's Institute, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
- Department of Psychology, University of Wisconsin-Madison, Madison, Wisconsin, USA.
- School of Nursing, University of Wisconsin-Madison, Madison, Wisconsin, USA.
ORCID-Profile: Gilda E Ennis
Förderung
- NIA NIH HHS
- National Institute on Aging - National Institutes of Health
- Swedish Research Council
- AD Strategic Fund
- UK Dementia Research Institute
- Hjärnfonden
- Alzheimer's Drug Discovery Foundation
- Olav Thon Foundation
Zitieren
APA
Ennis, G. E., Norton, D., Langhough, R. E., Gooding, D. C., Carter, F. P., Wilson, R., Zuelsdorff, M., Bouges, S., Asthana, S., Johnson, S. C., Zetterberg, H., & Gleason, C. E. (2025). The performance of plasma p‐tau217 in Black middle‐aged and older adults. Alzheimer's & Dementia. https://doi.org/10.1002/alz.70288
Vancouver
Ennis GE, Norton D, Langhough RE, Gooding DC, Carter FP, Wilson R, et al. The performance of plasma p‐tau217 in Black middle‐aged and older adults. Alzheimer's & Dementia. 2025. doi:10.1002/alz.70288
BibTeX
@article{Ennis2025,
author = {Ennis, Gilda E and Norton, Derek and Langhough, Rebecca E and Gooding, Diane C and Carter, Fabu P and Wilson, Rachael and Zuelsdorff, Megan and Bouges, Shenikqua and Asthana, Sanjay and Johnson, Sterling C and Zetterberg, Henrik and Gleason, Carey E},
title = {The performance of plasma p‐tau217 in Black middle‐aged and older adults},
journal = {Alzheimer's & Dementia},
year = {2025},
doi = {10.1002/alz.70288}
}
EUVIMED